 The current study aimed to explore the pharmacokinetics of temocillin in patients treated with haemodialysis and to demonstrated whether or not the pharmacodynamics target of a time above a MIC of 16 mgL of more than 40 and 60 of the dosing interval could be obtained with a dosing schedule of 1 gram24 hours, 2 gram48 hours and 3 gram72 hours, all of these doses given after haemodialysis sessions only. 